Back to Search
Start Over
Johns Hopkins investigators develop novel treatment for T-cell leukemias and lymphomas.
- Source :
- Cancer Gene Therapy Week; 4/15/2024, p220-220, 1p
- Publication Year :
- 2024
-
Abstract
- Researchers at the Johns Hopkins Kimmel Cancer Center have developed a novel treatment for T-cell leukemias and lymphomas. The treatment, called an antibody-drug conjugate (ADC), combines an antibody that targets a protein expressed on the surface of T-cell cancers with an anti-cancer drug. In mouse models, the treatment effectively killed T-cell cancers while preserving normal T cells. The researchers are now working with an industry partner to conduct early-phase trials in human patients. [Extracted from the article]
- Subjects :
- LEUKEMIA
T cells
LYMPHOMAS
LYMPHATIC diseases
BLOOD proteins
Subjects
Details
- Language :
- English
- ISSN :
- 15436837
- Database :
- Complementary Index
- Journal :
- Cancer Gene Therapy Week
- Publication Type :
- Periodical
- Accession number :
- 176547412